These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35560037)

  • 1. Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement demonstrating a biphasic histopathologic pattern and a complete natural regression.
    Kitajima Y; Yamashina M; Hanamoto M; Shijimaya T; Terai S; Nakamaru S; Makimura K; Inoue N; Takeuchi K; Kiyohara T
    J Dermatol; 2022 Sep; 49(9):e309-e310. PubMed ID: 35560037
    [No Abstract]   [Full Text] [Related]  

  • 2. DUSP22 rearrangement in primary cutaneous T cell lymphoma with features intermediate between mycosis fungoides, anaplastic large-cell lymphoma and lymphomatoid papulosis.
    Diaz de la Pinta FJ; Machan S; Manso Alonso R; Carvajal N; Nieves Salgado R; Piris MA; Rodriguez-Pinilla SM
    Histopathology; 2022 Jan; 80(2):446-449. PubMed ID: 34252219
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites.
    Zhang Y; Chen M; Yu Y; Liu X; Liu W; Jiang L; Zhang W
    J Cutan Pathol; 2022 Feb; 49(2):187-190. PubMed ID: 34622970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous anaplastic large-cell lymphoma with 6p25.3 rearrangement exhibits a biphasic histopathologic pattern: Two case reports and literature review.
    Xue YN; Wang Z; Sun JF; Chen H
    J Cutan Pathol; 2021 Dec; 48(12):1463-1470. PubMed ID: 34164830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological features and outcomes of DUSP22 rearrangement in primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
    Nieto-Benito LM; Parra-Blanco V; Gómez-Navarro Y; Menárguez-Palanca J; Pulido-Pérez A
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e670-e672. PubMed ID: 34014587
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Wang M; Kibbi N; Ring N; Siddon A; Foss F; Totonchy M
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31570354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1- immunophenotype.
    Chen BJ; Hsieh SM; Hsieh TH; Jhuang JY; Kao YC
    Hum Pathol; 2024 Aug; 150():58-66. PubMed ID: 38971328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-cell pattern of DUSP22 rearranged ALK-negative anaplastic large-cell lymphoma with leukemic phase.
    Aarakaki H; Karube K
    Blood; 2022 Jan; 139(3):465. PubMed ID: 35050329
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
    Hapgood G; Ben-Neriah S; Mottok A; Lee DG; Robert K; Villa D; Sehn LH; Connors JM; Gascoyne RD; Feldman AL; Farinha P; Steidl C; Scott DW; Slack GW; Savage KJ
    Br J Haematol; 2019 Aug; 186(3):e28-e31. PubMed ID: 30873584
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
    Boddicker RL; Feldman AL
    Biomark Med; 2015; 9(8):719-22. PubMed ID: 26223379
    [No Abstract]   [Full Text] [Related]  

  • 11. IRF4/DUSP22-positive anaplastic large cell lymphoma arising in the setting of chronic olecranon bursitis.
    Ku A; Alobeid B
    Blood; 2023 Jun; 141(23):2912. PubMed ID: 37289474
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.
    Niu N; Heberton MM; Tang Z; Aung PP; Nagarajan P; Curry JL; Prieto VG; Torres-Cabala CA; Cho WC
    J Cutan Pathol; 2023 Aug; 50(8):711-716. PubMed ID: 36944579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous anaplastic large cell lymphoma with DUSP22-rearrangement presenting as a mimicker of mycosis fungoides: a case report and review of the literature.
    Pacheco JM; Forchhammer S; Otto F; Fend F; Frauenfeld L
    Leuk Lymphoma; 2024 Feb; 65(2):265-269. PubMed ID: 37933677
    [No Abstract]   [Full Text] [Related]  

  • 14. Patch/plaque mycosis-fungoides-like presentations of DUSP22-translocated T-cell lymphomas.
    Runge JS; Novice ML; Briones N; Williams K; Lowe L; Boyer DF; Wilcox RA; Tejasvi T; Hristov AC
    J Cutan Pathol; 2022 Mar; 49(3):299-305. PubMed ID: 34699105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constant small-cell changes and variable LEF1 expression in DUSP22-rearranged primary cutaneous anaplastic large-cell lymphoma: Analysis of the repeated biopsies of three patients.
    Osakada A; Fujimoto M; Ueshima C; Kaku Y; Nishikori M; Inoue N; Takeuchi K; Haga H
    Pathol Int; 2023 Sep; 73(9):456-462. PubMed ID: 37530485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indolent ALK-negative anaplastic large-cell lymphoma, DUSP22 rearranged, with an unusual immunophenotype in a human immunodeficiency virus patient.
    Chapman J; Vega F
    Histopathology; 2017 Jun; 70(7):1173-1175. PubMed ID: 28042680
    [No Abstract]   [Full Text] [Related]  

  • 17. "Double-hit" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative.
    Karube K; Feldman AL
    Blood; 2020 Feb; 135(9):700. PubMed ID: 32106310
    [No Abstract]   [Full Text] [Related]  

  • 18. Co-occurring rearrangements of
    Klairmont MM; Ward N
    Leuk Lymphoma; 2022 Feb; 63(2):506-508. PubMed ID: 34612143
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.
    Yuan CT; Cheng AL; Hou HA
    Virchows Arch; 2023 Mar; 482(3):641-645. PubMed ID: 35984488
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Onaindia A; de Villambrosía SG; Prieto-Torres L; Rodríguez-Pinilla SM; Montes-Moreno S; González-Vela C; Piris MA
    Haematologica; 2019 Apr; 104(4):e158-e162. PubMed ID: 30361415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.